Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Serum Albumin Levels Predict Pneumonia Severity

By LabMedica International staff writers
Posted on 30 Jan 2013
The prognostic value of serum albumin levels in hospitalized adults with community-acquired pneumonia has been evaluated. More...


When serum albumin levels are measured within 24 hours of admission to the hospital, they can be correlated with the outcome of patients with community-acquired pneumonia (CAP).

Scientists at the University Hospital of Bellvitge (Barcelona, Spain) carried out a prospective cohort of adults with CAP requiring hospitalization from 1995 through 2011. Serum albumin results were obtained from the central laboratory database and were determined by a molecular absorption spectrometry utilizing bromocresol green. Pathogens in blood, normally sterile fluids, sputum, and other samples were investigated using standard microbiological procedures. Serum albumin levels were measured within 24 hours of admission. The primary end point was 30-day mortality.

During the study period, 3,463 patients with CAP required hospitalization. The median value of albumin was 31 g/L. As levels of serum albumin decrease, the risk of complications significantly increased. Decreased albumin levels were also significantly associated with prolonged time to reach clinical stability, prolonged hospital stay, intensive care unit (ICU) admission, the need for mechanical ventilation, and 30-day mortality. Hypoalbuminemia was documented in 1,307 (37.7%) patients, whose serum albumin was less than 30 g/L.

The authors concluded that hypoalbuminemia is frequent among hospitalized patients with CAP. Low serum albumin levels within 24 hours of hospital admission are significantly associated with increased risk of complications and poor outcome from CAP. Serum albumin is an objective and good prognostic marker in hospitalized adults with CAP. The study was published on December 31, 2012, in the Journal of Infection.

Related Links:

University Hospital of Bellvitge




Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
Pipette
Accumax Smart Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.